QNCX compared with LPCN: revenue, margins and what each company keeps, and the suppliers and customers both name

QNCXQuince Therapeutics, Inc.

Mkt capRevenueRevenue

LPCNLipocine Inc.

Mkt capRevenueRevenue

Compare

QNCXQuince Therapeutics, Inc.

LPCNLipocine Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

QNCX: latest quarter not drawable. LPCN: latest quarter is a loss; flow not drawable.Method ›

QNCXQuince Therapeutics, Inc.

33.00▼−1.64%· post 33.00· delayed

Mkt cap$34.1MRevenue—Revenue—

LPCNLipocine Inc.

1.46▲+0.66%· post 1.45· delayed

After hoursNov 3 '26delayed

Mkt cap$12.0MRevenue$190,099Q2 FY26Revenue$2MFY25

Compare

After hoursNov 3 '26delayed

QNCXQuince Therapeutics, Inc.

LPCNLipocine Inc.

33.00▼−1.64%post 33.00delayed

Price

1.46▲+0.66%post 1.45delayed

$34.1M

Mkt cap

$12.0M

—

Revenue

$190,099Q2 FY26

—

Revenue

$2MFY25

QNCX33.00▼−1.64%vsLPCN1.46▲+0.66%After hoursNov 3 '26delayed

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

No disclosed counterparties: QNCX, LPCN.

Role chip = supplier or customerSource: SEC EDGAR

Price

rebased to 0%

QNCX, solidLPCN, dashed